子類別 會議論文/會議摘要 [1/2] 期刊論文 [4/4] 鄰近社群 伍焜玉 [68/86] 何令君 [54/54] 劉俊揚 [55/63] 劉卜慈 [9/9] 吳志成 [26/26] 張中和 [20/22] 徐善慧 [72/76] 李啟明 [5/5] 李小玲 [11/11] 李華容 [8/12] 林秀芳 [72/80] 林聖光(2004-2017) [8/8] 梁啟銘(2007-2009) [2/2] 梁春金(2004-2009) [11/11] 楊良棟 [19/22] 王朝永 [19/19] 福井泰久(2010-2016) [14/16] 紀雅惠 [17/25] 裘正健 [40/44] 褚志斌 [113/120] 邱英明 [56/73] 郭呈欽 [56/71] 陳耀昌(2002-2004) [9/12] 顏伶汝 [71/88] 其他 [40/40] 社群統計 近3年內發表的文件:2(33.33%) 含全文筆數:5(83.33%) 文件下載次數統計 下載大於0次:5(100.00%) 下載大於100次:4(80.00%) 檔案下載總次數:667(0.01%) 最後更新時間: 2025-02-26 08:21 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Predicting clinically significant p... Prediction of clinically significan... Aspalathus linearis suppresses cell... Aspalathus linearis suppresses AKT ... Matriptase-2/NR4A3 axis switches TG... Crosstalk of post-translational mod...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-6 / 6. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2024-05-22	Predicting clinically significant prostate cancer using urine metabolomics via liquid chromatography mass spectrometry	World Journal of Mens Health. 2024 May 22;42:Article number e59.
2023-10-11	Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study	Journal of Translational Medicine. 2023 Oct 11;21:Article number 714.
2022-07-01	Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor	PLoS ONE. 2022 Jul 1;17(7):Article number e0270803.
2022-05	Matriptase-2/NR4A3 axis switches TGF-beta action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis	Oncogene. 2022 May;41(20):2833-2845.
2022-02	Aspalathus linearis suppresses AKT signaling, c-Myc, AR and survival of enzalutamide-resistant prostate cancer cells	Cancer Science. 2022 Feb;113(S1):1338.
2020-02	Crosstalk of post-translational modifications upon ERalpha activation	Cancer Research. 2020 Feb;80(4, Suppl.):Meeting Abstract P6-05-13.

顯示項目1-6 / 6. (共1頁) 1  每頁顯示[10|25|50]項目